Cited by — Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies.
No admitted local citation edges point to this work yet.
